Legorreta Pablo G.

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Legorreta Pablo G.'s trades of ProKidney Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
110.77
Quantity 8,189 +25.0%
Value US$2,768,210
Transaction date
Purchase
Price
404.80
Quantity 34,491 +16.6%
Value US$3,991,474
Transaction date
Purchase
Price
165.57
Quantity 70,341 +14.0%
Value US$1,390,119
Transaction date
Purchase
Price
33.00
Quantity 45,000 +11.8%
Value US$1,484,946
Transaction date
Purchase
Price
32.25
Quantity 150,000 +65.2%
Value US$4,837,440
Transaction date
Purchase
Price
32.94
Quantity 69,612 +43.4%
Value US$2,293,096
Transaction date
Purchase
Price
33.57
Quantity 160,388 +inf%
Value US$5,383,728
US Epizyme Inc (EPZM)
Transaction date
Purchase
Price
1.50
Quantity 22,666,667 +247.3%
Value US$34,000,000
Transaction date
Purchase
Price
28.00
Quantity 10,000 +inf%
Value US$280,000
Transaction date
Purchase
Price
28.00
Quantity 10,000 +inf%
Value US$280,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-14 2024-06-13
B Purchase
8,189 +25.0%
110.77
US$2,768,210 		8,189 +25.0% 110.77 US$2,768,210
2023-06-28 2023-06-28
B Purchase
34,491 +16.6%
404.80
US$3,991,474 		34,491 +16.6% 404.80 US$3,991,474
2023-06-13 2023-06-13
B Purchase
70,341 +14.0%
165.57
US$1,390,119 		70,341 +14.0% 165.57 US$1,390,119
2023-06-13 2023-06-12
B Purchase
45,000 +11.8%
33.00
US$1,484,946 		45,000 +11.8% 33.00 US$1,484,946
2023-05-24 2023-05-24
B Purchase
150,000 +65.2%
32.25
US$4,837,440 		150,000 +65.2% 32.25 US$4,837,440
2023-05-17 2023-05-17
B Purchase
69,612 +43.4%
32.94
US$2,293,096 		69,612 +43.4% 32.94 US$2,293,096
2023-05-17 2023-05-16
B Purchase
160,388 +inf%
33.57
US$5,383,728 		160,388 +inf% 33.57 US$5,383,728
2022-02-01 2022-01-31
US Epizyme Inc (EPZM)
B Purchase
22,666,667 +247.3%
1.50
US$34,000,000 		22,666,667 +247.3% 1.50 US$34,000,000
2020-06-22 2020-06-18
B Purchase
10,000 +inf%
28.00
US$280,000 		10,000 +inf% 28.00 US$280,000
2020-06-22 2020-06-18
B Purchase
10,000 +inf%
28.00
US$280,000 		10,000 +inf% 28.00 US$280,000